Petr Kocna

Dr. Petr Kocna

orcid

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2002 in Folia Microbiologica
Verified
Journal Article
Closed access
PDF file
ZVZ. Vančíková
Z. Vančíková
VCV. Chlumecký
V. Chlumecký
DSD. Sokol
D. Sokol
DHD. Horáková
D. Horáková
EHE. Hamšíková
E. Hamšíková
HTH. Tlaskalová-Hogenová
H. Tlaskalová-Hogenová

1 June 2021 in Clinica Chimica Acta
Verified
Journal Article
Closed access
SBSally C Benton
Sally C Benton
ESErin Leigh Symonds
Erin Leigh Symonds
NDNatasha Djedovic
Natasha Djedovic
SJSamantha Jones
Samantha Jones
LDLiesbet Deprez
Liesbet Deprez
JAJosep Maria Auge
Josep Maria Auge

1 February 1995 in Clinical Immunology and Immunopathology
Verified
Journal Article
Closed access
LTLudmila Tučková
Ludmila Tučková
HTHelena Tlaskalová-Hogenová
Helena Tlaskalová-Hogenová
MFMaria A. Farré
Maria A. Farré
KKKamila Karská
Kamila Karská
PRPavel Rossmann
Pavel Rossmann
PKPetr Kocna
Petr Kocna

1 January 2003 in Physiological Research
Verified
Journal Article
Closed access
JJJ Jiskra
J Jiskra
ZLZ Límanová
Z Límanová
ZVZ Vaníčková
Z Vaníčková
PKPetr Kocna
Petr Kocna
Celiac disease is a chronic illness of the small bowel caused by gliadin intolerance in genetically predisposed subjects. The aim of this study was to investigate serum levels of IgA and IgG antigliadin antibodies, IgA antiendomysial antibodies, and IgA anti-tissue transglutaminase antibodies in 169 patients with autoimmune thyroid diseases, i.e. chronic thyroiditis and Graves' disease. Antiendomysial antibodies were positive in 2 out of 169 persons (1.18%), IgA antigliadin antibodies in 15.98%, IgG antigliadin antibodies in 51.48%, and IgA anti-tissue transglutaminase in 14.79%. The prevalence of positivity was higher compared to the 1312 control blood donors described in our previous study (Vancíková et al. 2002) (p<0.05). Patients with chronic thyroiditis treated with a high replacement dosage of levothyroxin (125-200 microg daily) had higher serum levels of IgA antigliadin antibodies in comparison with patients treated with a lower dosage (50-100 microg daily) (medians: 13.00 vs. 19.69, p=0.033). We found a negative correlation of IgA anti-tissue transglutaminase antibodies and total calcium serum levels (r = -0.480, p=0.0236, n=22). We can conclude that in persons with autoimmune thyropathy there is a high prevalence of positive antigliadin, anti-tissue transglutaminase and antiendomysial antibodies. Latent celiac disease may lead to impaired resorption of therapeutically administered levothyroxine, calcium, or other substances.

1 February 1991 in European Food Research and Technology
Verified
Journal Article
Closed access
PDF file
PKPetr Kocna
Petr Kocna
TMThomas Mothes
Thomas Mothes
VKViktor Krchnak
Viktor Krchnak
PFPremysl Fric
Premysl Fric

1 May 1992 in Gut
Verified
Journal Article
Open access
PDF file
PFP Fric
P Fric
JSJ Slabý
J Slabý
EKE Kasafírek
E Kasafírek
PKPetr Kocna
Petr Kocna
JMJ Marek
J Marek
The six hour peritoneal lavage with glutaryl-trialanin-ethylamide, a low molecular competitive inhibitor of pancreatic elastase (IC50-8 mumol/l), effectively suppresses the evolution of taurocholate induced acute pancreatitis in the rat. The lavage alone is followed by a marked decrease of fat necrosis and amylase and lipase activity in serum. The area of pancreatic haemorrhage was significantly reduced only after the lavage solution was supplemented with Glt-Ala3-NHEt. The effect was not enhanced by a bolus injection of the inhibitor before starting the lavage. The combination of Glt-Ala3-NHEt with aprotinin or nafamstate mesilate produced only marginal greater benefit. The effect of Glt-Ala3-NHEt on pancreatic haemorrhage is time and dose related even with delayed onset of the lavage. Animals treated with peritoneal lavage without Get-Ala3-NHEt lived longer than controls (p less than 0.05), but by 60 hours the survival rate of both groups was almost the same (76 v 74%). All animals lavaged with Glt-Ala3-NHEt survived 120 hours and the difference in the survival rate between this and both remaining groups was significant (100% v 76% v 74% - p less than 0.05). The results were considered favourable and preliminary clinical trials of Glt-Ala3-NHEt in subjects with acute pancreatitis justified.